Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Thromboembolism × Ketoconazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 13 Neoplasms 3 Thromboembolism 1 Solid Tumors 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Chronic-Phase 1 Granulosa Cell Tumor 1 Genetic Diseases, Inborn 1 Castration-resistant Prostate Cancer 1 Breast Neoplasms 1

Interventions

alvocidib 1 Warfarin 1 Ketoconazole 1 Gemcitabine 1 Fondaparinux 1 Estramustine 1 Doxorubicin 1 Docetaxel 1 Dalteparin 1 Clopidogrel 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00014352 2013-01-16

Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed

Prostatic Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡